/SRTS

SRTS Stock - Sensus Healthcare, Inc.

Q: What is the analyst price target for SRTS?

Analyst price target information is not currently available for SRTS.

Q: What is SRTS's market cap?

Market capitalization information is not currently available for SRTS.

Healthcare|Medical - Devices|NASDAQ

$3.83-0.26%

$0.01 (-0.26%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+239.4%upside

Target: $13.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SRTS

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.24

52W High$9.08

52W Low$3.03

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$41.81M	$24.41M	$44.53M	$27.04M	$9.58M
Gross Profit	$24.43M	$14.06M	$29.63M	$16.99M	$5.25M
Gross Margin	58.4%	57.6%	66.5%	62.8%	54.8%
Operating Income	$8.09M	$-382,000	$14.83M	$4.12M	$-8,234,000
Net Income	$6.65M	$485,000	$24.24M	$4.12M	$-6,836,000
Net Margin	15.9%	2.0%	54.4%	15.2%	-71.4%
EPS	$0.41	$0.03	$1.47	$0.25	$-0.42

Company Overview

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

100%

Hold / Neutral

Sell / Underperform

Analyst Consensus🟢 Bullish

2 Bullish0 Neutral/Bearish

Price Targets

$16

Average Target

↑ 317.8% Upside

Now

$14

Low

$16

Average

$18

High

Based on 2 analysts

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
January 31st 2025	Lake Street	Initiation	Buy	$18
November 15th 2024	Maxim Group	Reiterated	Buy	$14← $12

Earnings History & Surprises

SRTS

Beat Rate

61%

Last 18 quarters

Avg Surprise

+26.9%

EPS vs Estimate

Beats / Misses

11/7

Last 12 quarters

Latest EPS

$-0.06

Q4 2025

EPS Surprise History

Q1 24

+116.7%

$0.26vs$0.12

Q2 24

+380.0%

$0.14vs$-0.05

Q3 24

+328.6%

$0.10vs$0.02

Q4 24

+799.7%

$0.07vs$0.01

Q1 25

-10.0%

$0.09vs$0.10

Q2 25

-500.0%

$-0.16vs$0.04

Q3 25

-700.0%

$-0.06vs$0.01

Q4 25

+45.5%

$-0.06vs$-0.11

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 13, 2026	—	—	—	—
Q1 2026	Feb 4, 2026	$-0.09	—	—	—
Q4 2025	Nov 6, 2025	$-0.11	$-0.06	+45.5%	✓ BEAT
Q3 2025	Aug 7, 2025	$0.01	$-0.06	-700.0%	✗ MISS
Q2 2025	May 15, 2025	$0.04	$-0.16	-500.0%	✗ MISS
Q1 2025	Feb 5, 2025	$0.10	$0.09	-10.0%	✗ MISS
Q4 2024	Nov 14, 2024	$0.01	$0.07	+799.7%	✓ BEAT
Q3 2024	Aug 8, 2024	$0.02	$0.10	+328.6%	✓ BEAT
Q2 2024	May 9, 2024	$-0.05	$0.14	+380.0%	✓ BEAT
Q1 2024	Feb 8, 2024	$0.12	$0.26	+116.7%	✓ BEAT
Q4 2023	Nov 9, 2023	$-0.02	$-0.09	-400.0%	✗ MISS
Q3 2023	Aug 3, 2023	$-0.05	$-0.02	+60.0%	✓ BEAT
Q2 2023	May 3, 2023	$0.11	$-0.12	-209.1%	✗ MISS
Q1 2023	Feb 9, 2023	$0.23	$0.17	-26.1%	✗ MISS
Q4 2022	Nov 3, 2022	$0.13	$0.11	-15.4%	✗ MISS
Q3 2022	Aug 4, 2022	$0.13	$0.21	+61.5%	✓ BEAT
Q2 2022	May 5, 2022	$0.06	$0.20	+233.3%	✓ BEAT
Q1 2022	Feb 10, 2022	$0.16	$0.32	+100.0%	✓ BEAT
Q4 2021	Nov 4, 2021	$0.00	$0.01	+159.7%	✓ BEAT
Q3 2021	Aug 5, 2021	$-0.05	$-0.02	+60.0%	✓ BEAT

Frequently Asked Questions about SRTS

What is SRTS's current stock price?

Sensus Healthcare, Inc. (SRTS) is currently trading at $3.83 per share. The stock has moved -0.26% today.

What is the analyst price target for SRTS?

The average analyst price target for SRTS is $13.00, based on 1 analyst.

What sector is Sensus Healthcare, Inc. in?

Sensus Healthcare, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.

What is SRTS's market cap?

Sensus Healthcare, Inc. has a market capitalization of $0.06 billion, making it a small-cap company.

Does SRTS pay dividends?

No, Sensus Healthcare, Inc. does not currently pay a dividend to shareholders.